CTLA4 and neoplasm: Similarly, Zamarin et al.[27] demonstrated that protection against tumour rechallengedoubles when treated with NDV and anti‐CTLA‐4 combination therapycompared with mice treated with anti‐CTLA‐4 therapy alone, enhancingtumour lymphocyte infiltration.